ncats

Toward the Efficient Discovery of Actionable Chemical Matter from DNA-encoded Libraries

49:25

NCATS’ Stem Cell Translation Laboratory

5:06

Strategies for Assay Selection and for the Development of Robust Biochemical Assays

50:49

NCATS, the National Center for Advancing Translational Sciences

5:16

In Vitro Assessment of ADME Properties of Lead Compounds

1:02:26

Lead Selection and Optimization by Medicinal Chemistry

38:12

Antibody Binding Sites as Therapeutics: From scFv to VHH and VNAR

47:25

NCATS Rare Diseases–Jennifer Payne

2:48

Biophysical Approaches to Small Molecule Discovery and Validation

42:22

Lab tour — TDB Medicinal Chemistry Program, NCATS

6:38

NCATS Drug Metabolism and Pharmacokinetic Core — Virtual Lab Tour 2022

13:29

Inside the NCATS Laboratories

7:13

Biomedical Translation

3:14

COVID19: The NCATS Experience

42:50

I Am Translational Science: Brittany M. Haynes, Ph.D., NCATS

3:54

NCATS Rare Diseases–Marcela Ferrada

2:35

High Content Imaging Applications: Best Practices and Approaches to Consider

49:44

CCIA Technical Assistance Webinar

1:21:48

I Am Translational Science: Lucie A. Low, Ph.D., NCATS

4:16

Overview of Sampling in Qualitative Research

3:53

NCATS Biomedical Data Translator Program

3:40

Craig Thomas, Ph.D., on How a Tumor Cell's Location and Environment Affect Its Identity

3:06

NCATS Team Creates Astrocytes Faster From Stem Cells for Drug Development and Regenerative Medicine

3:15

Keynote Presentation: NCATS Automation Capabilities - Where We Are and Where We Are Going

1:04:07

NIH Global Unique Identifier (GUID)

3:36

Tissue Chip for Drug Screening Program at NCATS

3:50

Case Studies in Translational Science: Metarrestin for Cancer Metastasis

5:41

NCATS i3D-Rare Workshop

7:12:45

ADST Chemical Biology Laboratory at NCATS

9:19

Why You Want to Use Stem Cells for Drug Discovery

45:28

Basic Assay Statistics, Data Analysis & Rules of Thumb (ROT)

47:15

Biomedical Data Translator Architecture and Workflow

20:38

Finding Treatment Information

4:48

Tips for the Undiagnosed

4:23

Case Studies in Translational Science: Partnering on Rare Diseases Research

4:01

NCATS Rare Diseases–Megan O'Boyle

2:45

Rare Disease Research at NCATS presented by Tiina Urv, PhD

20:16

Ex Vivo vs In Vivo Gene Therapy

2:00

Support for Women Entrepreneurs and Researchers in Biotech Webinar

1:07:07

NCATS Rare Diseases–Jessie McQuillen

3:07

Rare Diseases Research: Clinical Trial for Niemann-Pick Type C

10:59

National COVID Cohort Collaborative (N3C) Demonstration

8:06

NIA SBIR/STTR Virtual Workshop: Understanding the NIH Peer-Review Process

2:01:49

I Am Translational Science: Anne R. Pariser, M.D., NCATS

4:36

[DeclMed'23] NCATS' Biomedical Data Translator - Connecting the Dots

45:33

TOX21: A New Way to Evaluate Chemical Safety and assess risk

6:29

NCATS Director's Welcoming on Rare Disease Day

6:55

Office of Rare Diseases Research, NCATS Welcoming Rare Disease Advocates

10:58

Rare Diseases are Not Rare – A Training on Rare Disease Resources

57:10

2015 NCATS Clarington 200 at CTMP Final Restart + Finish

7:00

I Am Translational Science: Kirill Gorshkov, Ph.D., NCATS

3:15

I Am Translational Science: Christopher Austin, M.D., Flagship Pioneering

3:40

What is a control group?

2:07

Case Studies in Translational Science: Tissue Chips (Audio Description)

8:47

2021 Three-minute Talk (TmT) - David Morse, B.A., Predoc, NCATS

3:16

Accelerating Health Innovation through I-Corps@NCATS

4:33

Safety Evaluation & Toxicology ASR Review Video 2022

8:47

2022 Three-minute Talk (TmT) - Ivan Pavlinov, Postdoc, NCATS

2:39

Inhibitors of NSD2 Discovered by High-Throughput Screening with a Nucleosome Substrate

52:47

Compound-mediated Interferences in Homogeneous Proximity Assays

45:32